Modrasil (Sildenafil Citrate)

Sildenafil, the active ingredient in Modrasil, is a phosphodiesterase type 5 inhibitor presented as an oral tablet for oral use. It treats erectile dysfunction and pulmonary arterial hypertension in adult patients.

GNH USA supplies Modrasil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Modrasil is a phosphodiesterase type 5 inhibitor used in conditions affecting vascular smooth muscle tone. - Erectile dysfunction: improves the ability to achieve and maintain an erection. - Pulmonary arterial hypertension: enhances exercise capacity and reduces pulmonary arterial pressure. - Erectile dysfunction in men with diabetes: improves erectile response in diabetic patients.

Common Side Effects: - Headache - Flushing - Dyspepsia - Nasal congestion

Serious or Rare Side Effects: - Priapism (prolonged erection) - Severe hypotension - Sudden hearing loss

Before prescribing Modrasil, consider the following precautions: - Cardiovascular assessment: evaluate for recent myocardial infarction or unstable angina. - Nitrate use: avoid co‑administration with any nitrate medication. - Hepatic/renal function: adjust use in severe impairment. - Visual disorders: caution in patients with retinitis pigmentosa. - Sexual activity timing: advise patients to wait for the drug’s effect to subside before repeated dosing. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Modrasil may interact with several medicines.

Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin) - Guanylate cyclase stimulators (e.g., riociguat) - Protease inhibitors (e.g., ritonavir)

Moderate Interactions (Monitor Closely):\n- Strong CYP3A4 inhibitors (e.g., erythromycin) - Strong CYP3A4 inducers (e.g., rifampicin)